A Potential Role for the Myeloid Lineage in Leptin-regulated Bone Metabolism

 

 Buy Article Permissions and Reprints

Abstract

Leptin influences bone formation centrally through the hypothalamus and peripherally by acting on osteoblasts or their precursors. However, neither mechanism explains the divergent, gender-specific correlation between leptin and bone mineral density in humans. Although leptin is a potent regulator of pro-inflammatory immune responses, a potential role for leptin as an osteoimmunologic intermediate in bone metabolism has not been tested. Mice with myeloid-specific ablation of the long-form leptin receptor (ObRb) were generated using mice expressing cre-recombinase from the lysoszyme M promoter. At 12 weeks of age, the conditional knockout mice did not display any appreciable phenotype. However, at 52 weeks 2 changes were noted. First, there was a mild increase in liver inflammation. Second, a gender-specific, divergent bone phenotype was observed. Female mice displayed a consistent trend toward decreased trabecular bone parameters including reductions in bone volume fraction, trabecular number, and bone mineral content as well as a significant increase in marrow adipogenesis. Conversely, male mice lacked trabecular changes, but had statistically significant increases in cortical bone volume, thickness, and bone mineral density with equivalent total cortical volume. Since the year 2000, over 25 studies on more than 10 000 patients have sought to determine the correlation between leptin and bone mineral density. The results revealed a gender-specific correlation similar to that observed in our LysM transgenic animals. We hypothesize and show new evidence that regulation of myeloid lineage cells by leptin may facilitate their actions as an osteoimmunologic intermediate and contribute to leptin-regulated bone formation and metabolism in a gender-specific manner.

• References

• 1 Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543
  CrossrefPubMedGoogle Scholar
• 2 Breslow MJ, Min-Lee K, Brown DR, Chacko VP, Palmer D, Berkowitz DE. Effect of leptin deficiency on metabolic rate in ob/ob mice. Am J Physiol 1999; 276: E443-E449
  PubMedGoogle Scholar
• 3 La Cava A, Matarese G. The weight of leptin in immunity. Nat. Rev 2004; 4: 371-379
  PubMedGoogle Scholar
• 4 Scheller EL, Song J, Dishowitz MI, Soki FN, Hankenson KD, Krebsbach PH. Leptin functions peripherally to regulate differentiation of mesenchymal progenitor cells. Stem Cells (Dayton, Ohio) 2010; 28: 1071-1080
  CrossrefPubMedGoogle Scholar
• 5 Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000; 100: 197-207
  CrossrefPubMedGoogle Scholar
• 6 Gruen ML, Hao M, Piston D, Hasty AH. Leptin requires canonical migratory signaling pathways for induction of monocyte and macrophage chemotaxis. Am J Physiol Cell Physiol 2007; 293: C1481-C1488
  CrossrefPubMedGoogle Scholar
• 7 Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM. Leptin regulates proinflammatory immune responses. FASEB J 1998; 12: 57-65
  PubMedGoogle Scholar
• 8 Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 1999; 194: 6-11
  CrossrefPubMedGoogle Scholar
• 9 Gainsford T, Willson TA, Metcalf D, Handman E, McFarlane C, Ng A, Nicola NA, Alexander WS, Hilton DJ. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci USA 1996; 93: 14564-14568
  CrossrefPubMedGoogle Scholar
• 10 Zhao T, Hou M, Xia M, Wang Q, Zhu H, Xiao Y, Tang Z, Ma J, Ling W. Globular adiponectin decreases leptin-induced tumor necrosis factor-alpha expression by murine macrophages: involvement of cAMP-PKA and MAPK pathways. Cell Immunol 2005; 238: 19-30
  CrossrefPubMedGoogle Scholar
• 11 Maingrette F, Renier G. Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C. Diabetes 2003; 52: 2121-2128
  CrossrefPubMedGoogle Scholar
• 12 Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Eng J Med 1996; 334: 292-295
  CrossrefPubMedGoogle Scholar
• 13 Thomas T, Burguera B, Melton 3rd LJ, Atkinson EJ, O’Fallon WM, Riggs BL, Khosla S. Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone 2001; 29: 114-120
  CrossrefPubMedGoogle Scholar
• 14 Ruhl CE, Everhart JE. Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res 2002; 17: 1896-1903
  CrossrefPubMedGoogle Scholar
• 15 Lorentzon M, Landin K, Mellstrom D, Ohlsson C. Leptin is a negative independent predictor of areal BMD and cortical bone size in young adult Swedish men. J Bone Miner Res 2006; 21: 1871-1878
  CrossrefPubMedGoogle Scholar
• 16 Zhong N, Wu XP, Xu ZR, Wang AH, Luo XH, Cao XZ, Xie H, Shan PF, Liao EY. Relationship of serum leptin with age, body weight, body mass index, and bone mineral density in healthy mainland Chinese women. Clin Chim Acta 2005; 351: 161-168
  CrossrefPubMedGoogle Scholar
• 17 Chang YJ, Shih DT, Tseng CP, Hsieh TB, Lee DC, Hwang SM. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells (Dayton, Ohio) 2006; 24: 679-685
  CrossrefPubMedGoogle Scholar
• 18 Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999; 140: 1630-1638
  CrossrefPubMedGoogle Scholar
• 19 Shi Y, Yadav VK, Suda N, Liu XS, Guo XE, Myers Jr MG, Karsenty G. Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proc Natl Acad Sci USA 2008; 105: 20529-20533
  CrossrefPubMedGoogle Scholar
• 20 Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 1999; 8: 265-277
  CrossrefPubMedGoogle Scholar
• 21 McMinn JE, Liu SM, Dragatsis I, Dietrich P, Ludwig T, Eiden S, Chua Jr SC. An allelic series for the leptin receptor gene generated by CRE and FLP recombinase. Mamm Genome 2004; 15: 677-685
  CrossrefPubMedGoogle Scholar
• 22 Menahan LA. Age-related changes in lipid and carbohydrate metabolism of the genetically obese mouse. Metabolism: clinical and experimental 1983; 32: 172-178
  PubMedGoogle Scholar
• 23 Hamrick MW, Pennington C, Newton D, Xie D, Isales C. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 2004; 34: 376-383
  CrossrefPubMedGoogle Scholar
• 24 Chang MK, Raggatt LJ, Alexander KA, Kuliwaba JS, Fazzalari NL, Schroder K, Maylin ER, Ripoll VM, Hume DA, Pettit AR. Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol 2008; 181: 1232-1244
  PubMedGoogle Scholar
• 25 Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H, Swick AG. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept 2000; 92: 73-78
  CrossrefPubMedGoogle Scholar
• 26 Kawashima H, Castro A. Effect of 1 alpha-hydroxyvitamin D3 on the glucose and calcium metabolism in genetic obese mice. Res Commun Chem Pathol Pharmacol 1981; 33: 155-161
  PubMedGoogle Scholar
• 27 Williams GA, Callon KE, Watson M, Costa JL, Ding Y, Dickinson M, Wang Y, Naot D, Reid IR, Cornish J. Skeletal phenotype of the leptin receptor-deficient db/db mouse. J Bone Miner Res 2011; 26: 1698-1709
  CrossrefPubMedGoogle Scholar